Contract manufacturing of biopharmaceuticals is becoming an increasingly popular option.BERKELEY, Calif.--(BUSINESS WIRE)--June 20, 1995--More than 1,300 biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. worldwide are seeking their fortune in the biopharmaceutical market. Yet for most, the dream of building a manufacturing facility is fading as investment funds Noun 1. investment funds - money that is invested with an expectation of profit investment assets - anything of material value or usefulness that is owned by a person or company for biotechnology companies continue to decrease. The options for those companies that cannot build their own manufacturing facility is to partner with a large pharmaceutical company to access high-quality good-manufacturing-practices (GMP GMP (guanosine monophosphate): see guanine. ) manufacturing capability, or to outsource. Outsourcing, which allows biotechnology companies to maintain control and ownership of their own product, is becoming an increasingly popular option. Although currently a small industry, dedicated biopharmaceutical contract manufacturers are planning for expansion. In a recent study of the industry, Technology Forecasters found that more than half of current contract manufacturers are planning to expand services to meet growing demand. Out of 20 companies interviewed, six are planning to build new GMP manufacturing facilities. Celltech Biologics (Slough Slough (slou), city (1991 pop. 106,341) and borough, central England. After World War I, the residential city and its outlying area underwent rapid industrial development, owing in part to its proximity to London. , U.K.) has just expanded by building a 76,000 square foot biomanufacturing facility in Portsmouth, New Hampshire Portsmouth, New Hampshire is a city in Rockingham County, New Hampshire in the United States of America. It is the fourth-largest community in the county[1], with a population of 20,784 as of the 2000 census. . Celltech specializes in monoclonal antibody monoclonal antibody, an antibody that is mass produced in the laboratory from a single clone and that recognizes only one antigen. Monoclonal antibodies are typically made by fusing a normally short-lived, antibody-producing B cell (see immunity) to a fast-growing production. Bio Science Contract Production Corp. (Baltimore, MD) is planning to open its new 54,000 square foot multi-user GMP facility later this year. Bio-Intermediar B.V. (Groningen, The Netherlands) will soon begin building a facility in Montreal, Quebec, Canada to establish a presence in North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. . Goodwin Biotechnology (Plantation, FL), Baxter Biotech bi·o·tech n. Informal Biotechnology. biotech Noun short for biotechnology Noun 1. Group (Glendale, CA), and Alberta Research Group (Edmonton, Alberta, Canada) are also building. Robert McKown, Ph.D., biotechnology consultant at Technology Forecasters, says, "With biotechnology companies short on cash, and more products moving through the pipeline, contract manufacturers are seeing increased demand for their services. Dedicated contractors are building new facilities to meet this demand, and biotechnology companies with their own GMP facilities recognize an opportunity to fill excess capacity by offering contract manufacturing services." Biotechnology companies such as Genzyme Corp. (Cambridge, MA), Immunex Corp. (Seattle, WA), Repligen Corp. (Cambridge, MA), and Xoma Corp. (Berkeley, CA) are currently offering contract manufacturing services in their GMP facilities. CONTACT: Technology Forecasters, Inc. Sandra Fox or Dr. Robert McKown, 510/849-1995 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion